Try our corporate solution for free!
(212) 419-8286
hadley.ward@statista.com

Cumulative price change of orphan drugs in the U.S. 2012-2014

This statistic depicts the cumulative percentage increase in price for select orphan drugs in the United States between 2012 and 2014. According to the data, orphan drug Gralise has increased in price by 113.5 percent over the given period.

Percentage cumulative price change among select orphan drugs in the U.S. between 2012 and 2014

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

October 2016

Region

United States

Survey time period

01 January 2012 to 31 December 2014

Supplementary notes

* The cumulative price change is based on changes in the unit price for NDC #00173-0806-01 & #53451-0101-01.
** As Iclusig was not approved by the FDA until December, 2012 it was included in the study; however, its pricing and utilization data were from 2013 to 2014 only.
*** Includes patients prescribed Myozyme.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Pharmaceutical trends in Europe"

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.